Published: November 12, 2012
AstraZeneca Launches New Digital Resources for ARIMIDEX (anastrozole) Tablets to Help Educate Patients About ARIMIDEX Direct
WILMINGTON, Del. - (BUSINESS WIRE) - AstraZeneca (NYSE: AZN) today launched new digital resources to educate
patients on how to enroll in ARIMIDEX
Direct. Resources include a "how to" video
outlining the enrollment process for ARIMIDEX Direct and a digital
badge that can be shared via social media platforms and symbolizes
support for the program.
Breast cancer treatments can impact patients financially. In fact,
research has found that the estimated lifetime costs of medical care for
breast cancer patients in the United States can be up to $100,000.1
However, there are programs like AstraZeneca's ARIMIDEX Direct,
which can help reduce financial strain for patients taking ARIMIDEX.
ARIMIDEX is approved for adjuvant treatment (treatment following surgery
with or without radiation) of postmenopausal women with hormone
receptor-positive early breast cancer. Prescription ARIMIDEX is only for
postmenopausal women. ARIMIDEX should not be taken if you are pregnant
because it may harm your unborn child. Do not take ARIMIDEX if you are
allergic to any of its ingredients. Additional Important Safety
Information provided below.
To read the complete release at NewsBlaze,
AstraZeneca Launches New Digital Resources for ARIMIDEX (anastrozole) Tablets to Help Educate Patients About ARIMIDEX Direct,
Related Business Wire News
DishLATINO joins Copa Univision, the fastest growing amateur soccer tournament in the U.S., to bring family fun, entertainment and soccer to Miami's Hispanic community this weekend. Copa Univision will take place on May 18-19, 2013 at the Amelia ...
AMF Bowling Worldwide filed a new chapter 11 plan of reorganization sponsored by Bowlmor and certain of AMF's second lien lenders, including Cerberus Series Four Holdings, LLC and Credit Suisse.
Addivant USA, LLC, the global leader in specialty additives with regional headquarters in Shanghai, China, will exhibit in Hall 11.2, stand M25 and host a technical seminar for customers during Chinaplas 2013. Chinaplas 2013, 17th International ...
Addivant USA, LLC, the global leader in specialty additives, will exhibit in Booth E 68 during Feiplastic 2013, 17th International Plastic Trade Fair, a global meeting of industry leaders to be held from May 20th-24th at Anhembi Exhibition Pavilion,...
May 5 th Interview, Posted on TakePart TV http://youtu.be/f8_TkG04bHU is One of Few Fayyad Has Given since Resigning from Office
Deutsche Asset & Wealth Management today announced the addition of the db X-trackers MSCI Germany Hedged Equity Fund to the db X-trackers platform, effective May 31, 2013. DBGR is the first ETF designed to provide investors direct exposure to ...